The Hypertensive Plate: Unravelling Dietary Culprits in Hypertension
Article Sidebar
Main Article Content
Abstract
Hypertension remains a leading global health challenge, significantly increasing the risk of cardiovascular disease, stroke, and kidney failure. While genetic predisposition plays a role, dietary habits are among the most critical modifiable risk factors influencing blood pressure regulation. Emerging research highlights the detrimental effects of excessive sodium intake, refined sugars, unhealthy fats, ultra-processed foods, and alcohol consumption in elevating blood pressure. These dietary components contribute to endothelial dysfunction, oxidative stress, inflammation, and metabolic disturbances, all of which exacerbate hypertension. Conversely, nutrient-rich dietary patterns such as the DASH and Mediterranean diets have been extensively studied for their beneficial effects on blood pressure control, emphasizing the role of potassium, magnesium, fiber, and healthy fats in vascular health.
Recent advancements have also shed light on the gut microbiome’s role in diet-induced hypertension, opening new avenues for research on personalized nutrition and functional foods. Future studies should focus on long-term dietary interventions, the impact of bioactive compounds, and the integration of genetics and microbiome science into hypertension management. Public health initiatives must prioritize reducing sodium and sugar content in processed foods, increasing awareness about heart-healthy diets, and implementing policies that support healthier food choices. A holistic approach, incorporating dietary education, lifestyle modifications, and early interventions, is essential to curb the growing burden of hypertension worldwide. This review provides a comprehensive overview of the dietary factors influencing hypertension, recent research trends, and future directions, underscoring the importance of nutrition-based strategies in hypertension prevention and management.
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
All open access articles published in the journal are distributed under the terms of the CC-BY-NC-SA 4.0 license (Creative Commons Attribution-Non-commercial-ShareAlike 4.0 International License) which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original work is properly cited and distributed under the same license (ShareAlike). Under Creative Commons, authors retain copyright in their articles.
References
World Health Organization. Hypertension. Global Health Observatory. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension
Mente A, O'Donnell M, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2018;378(7):603-13.
Geleijnse JM, Witteman JC, Stijnen T, Kromhout D. Long-term effects of a diet high in polyunsaturated fat on blood pressure. J Hypertens. 2020;38(1):30-6.
Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the DASH diet. N Engl J Med. 2019;344(1):3-10
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA Hypertension Guidelines. Hypertension. 2018;71(6):e13-e115.
Adrogué HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2014;371(7):629-39.
DiNicolantonio JJ, Lucan SC, O’Keefe JH. The evidence for saturated fat and sugar leading to coronary heart disease. Prog Cardiovasc Dis. 2016;58(5):464-72.
Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease. Circulation. 2020;141(9):664-82.
Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2018;71(1):68-77.
He FJ, Tan M, Ma Y, MacGregor GA. Salt reduction to prevent hypertension and cardiovascular disease. Nat Rev Cardiol. 2020;17(4):181-96
Farquhar WB, Edwards DG, Jurkovitz CT, Weintraub WS. Dietary sodium and health: More than just blood pressure. J Am Coll Cardiol. 2015;65(10):1042-50.
Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005;85(2):679-715.
O’Donnell M, Mente A, Alderman MH, Brady AJ, Diaz R, Gupta R, et al. Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. Eur Heart J. 2020;41(35):3363-73.
Stanhope KL. Sugar consumption, metabolic disease and obesity: The state of the controversy. Crit Rev Clin Lab Sci. 2016;53(1):52-67.
Brown IJ, Stamler J, Van Horn L, Robertson CE, Chan Q, Daviglus ML, et al. Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: International study of macro/micronutrients and blood pressure. Hypertension. 2019;73(3):543-50.
Sanchez-Lozada LG, Mu W, Roncal C, Sautin YY, Abdelmalek M, Reungjui S, et al. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. Eur J Nutr. 2010;49(1):1-9.
Malik VS, Popkin BM, Bray GA, Després JP, Hu FB. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation. 2014;129(3):247-62.
Mensink RP. Effects of saturated fatty acids on serum lipids and lipoproteins: A systematic review and regression analysis. World Health Organization. 2016;1-47.
Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354(15):1601-13.
Wang DD, Hu FB. Dietary fat and risk of cardiovascular disease: Recent controversies and advances. Annu Rev Nutr. 2017;37:423-46.
de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, et al. Intake of saturated and trans unsaturated fatty acids and risk of all-cause mortality, cardiovascular disease, and type 2 diabetes: Systematic review and meta-analysis of observational studies. BMJ. 2015;351:h3978.
Monteiro CA, Cannon G, Levy RB, Moubarac JC, Louzada ML, Rauber F, et al. Ultra-processed foods: what they are and how to identify them. Public Health Nutr. 2018;21(1):5-11.
Fardet A. Minimally processed foods are more satiating and less hyperglycemic than ultra-processed foods: A preliminary study. Eur J Clin Nutr. 2016;70(5):647-9.
He FJ, Tan M, Ma Y, MacGregor GA. Salt reduction to prevent hypertension and cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(6):632-47.
Harper CR, Powell ML. The effect of artificial sweeteners on metabolic regulation. Curr Diab Rep. 2021;21(6):20.
Martínez Steele E, Baraldi LG, Louzada ML, Moubarac JC, Mozaffarian D, Monteiro CA. Ultra-processed foods and added sugars in the US diet: Evidence from a nationally representative cross-sectional study. BMJ Open. 2019;6(3):e009892.
Clark A, Landrum EC. The effects of alcohol on blood pressure and hypertension. Curr Hypertens Rep. 2020;22(1):1-10.
Piano MR. Alcohol’s effects on blood pressure regulation. Alcohol Res. 2017;38(2):219-26.
Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2018;104(12):1981-90.
Cornelis MC, Monda KL, Yu K, Paynter N, Azzato EM, Bennett SN, et al. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) that influence habitual caffeine consumption. PLoS Genet. 2018;7(4):e1002033.
Driessen AK, Peeters L, Pinkham C, Teede H, Lombard C. Caffeine and cardiovascular health: A review of current evidence and future directions. Nutrients. 2021;13(8):2672.
Zhang Z, Cogswell ME, Gillespie C, Fang J, Loustalot F, Dai S, et al. Association of urinary sodium and potassium excretion with blood pressure. JAMA. 2020;322(2):147-56.
Filippini T, Violi F, D’Amico R, Vinceti M. The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis. Int J Cardiol. 2020;294:61-9.
Zhang W, Zhang S, Wang C, Wang X, Wan H, Zhang H, et al. Magnesium intake and cardiovascular disease risk: A meta-analysis. Nutrients. 2021;13(3):755.
Kass LS, Sullivan K, Schluter K, Haq S. Dietary magnesium intake and risk of hypertension: A meta-analysis of prospective cohort studies. BMC Med. 2018;16(1):210.
Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Aros F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2018;378(25):2441-54.
Duffy SL, Jacka FN, Strazdins L, Pizzinga J, Mellor D, Williams S, et al. The influence of the Western dietary pattern on mental health: A systematic review and meta-analysis. Psychosom Med. 2020;82(6):561-71.
Kim Y, Lee H, Park S. The impact of the gut microbiome on hypertension. Curr Hypertens Rep. 2020;22(10):80.
Wang Y, Wu Y, Liu S, Liang Y. The role of gut microbiota in regulating hypertension: An emerging avenue for prevention and treatment. J Hypertens. 2021;39(7):1222-30.
Shivappa N, Hebert JR, Wirth MD, Steck SE. The role of plant-based diets in hypertension prevention. Nutrients. 2021;13(5):1685.
Zhang Z, Yang J, Li C, Zhang H, Zhang W. Dietary bioactive compounds and hypertension: A systematic review of intervention studies. J Nutr. 2022;152(2):373-85
Cappuccio FP, Miller MA, Lacy P, Walker K. Salt reduction in the prevention of cardiovascular disease: A systematic review. J Hypertens. 2019;37(10):1953-60.
James WPT, Thomas P, Cummings J, O’Brien N. Public health strategies for managing hypertension. J Clin Hypertens. 2020;22(6):968-77.
Zhao Y, Li S, Wang H, Zhang X, Chen C, Zhang M. The impact of public health policies on hypertension prevalence and management: Evidence from tax and subsidy experiments. Lancet Public Health. 2021;6(8):e539-47.
Singh R, Roy S, Ghildiyal A, Verma S. Association of Anthropometry With Nerve Conduction Parameters of Median Nerve: A Cross-Sectional Study in a North Indian Medical University Hospital. Cureus. 2024 Jul 6;16(7):e63946. doi: 10.7759/cureus.63946. PMID: 39105004; PMCID: PMC11299048.
Tiwari R, Singh S, Bajpai M, Verma N, Verma S. Impact of Osteocalcin on Glycemic Regulation and Insulin Sensitivity in Type 2 Diabetes Mellitus Patients. Cureus. 2024 Oct 17;16(10):e71675. doi: 10.7759/cureus.71675. PMID: 39553160; PMCID: PMC11568420.
Tiwari R, Singh N, Singh S, Bajpai M, Verma S. Interplay of Adiponectin With Glycemic and Metabolic Risk Metrics in Patients With Diabetes. Cureus. 2024 Sep 30;16(9):e70543. doi: 10.7759/cureus.70543. PMID: 39479098; PMCID: PMC11524515.
Tiwari R, Verma S, Verma N, Verma D, Narayan J. Correlation of serum uric acid levels with certain anthropometric parameters in prediabetic and drug-naive diabetic subjects. Ann Afr Med. 2024 Jan-Mar;23(1):13-18. doi: 10.4103/aam.aam_40_22. PMID: 38358165; PMCID: PMC10922179.
Verma S, Tiwari R, Verma N, Singh S, Sharma A. Anthropometry and blood biomarkers of diabetes and their possible association with obesity and metabolic syndrome. J Diabetes Metab Disord. 2023 Oct 11;23(1):509-517. doi: 10.1007/s40200-023-01276-4. PMID: 38932840; PMCID: PMC11196461.